Related content

Intravenous albumin does not prevent moderate‐severe ovarian hyperstimulation syndrome in high‐risk IVF patients: a randomized controlled study

By Bellver José   Muñoz Elkin A.   Ballesteros Agustín   Soares Sérgio Reis   Bosch Ernesto   Simón Carlos   Pellicer Antonio   Remohí José  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2283-2288

Oxford University Press

Access to resources Recommend Favorite

Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme.

By Graf M A   Fischer R   Naether O G   Baukloh V   Tafel J   Nückel M  

Human Reproduction, Vol. 12, Iss. 12, 1997-12 ,pp. : 2599-2602

Oxford University Press

Access to resources Recommend Favorite

The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial

By Busso Cristiano   Fernndez-Snchez Manuel   Garca-Velasco Juan Antonio   Landeras Jos   Ballesteros Augustn   Muoz Elkin   Gonzlez Sandra   Simn Carlos   Arce Joan-Carles   Pellicer Antonio  

Human Reproduction, Vol. 25, Iss. 4, 2010-04 ,pp. : 995-1004

Oxford University Press

Access to resources Recommend Favorite

Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study

By Penna I.A.A.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2396-2401

Oxford University Press

Access to resources Recommend Favorite

Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study

By Rolf C   Cooper TG   Yeung CH   Nieschlag E  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 1028-1033

Oxford University Press

Access to resources Recommend Favorite